Torrent Pharma approves equity + convertible bond fund raise

What's the deal? Torrent PharmaceuticalsDealroom has a profile for this one. Try Dealroom → has approved a plan to raise funds through a combination of equity and convertible bonds. The Indian pharmaceutical company's board gave the green light for the capital raise, though specific details on the size and timing remain scarce.

The signal: Dealroom classifies Torrent Pharma as an "early growth" stage company, and opting for a hybrid equity-and-convertible-bond structure is a classic move for firms at that inflection point — seeking substantial capital for expansion while minimising immediate shareholder dilution. The approach signals confidence that the company's valuation trajectory will make conversion attractive to bondholders down the line.

Read more: ainvest.com